Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative
Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Archives Of Dermatological Research 2018, 310: 701-710. PMID: 30167814, DOI: 10.1007/s00403-018-1855-3.Peer-Reviewed Original ResearchConceptsInternational Dermatology Outcome MeasuresPsA symptomsPsoriasis clinical trialsPsoriatic arthritisClinical trialsHealth Measurement INstruments (COSMIN) guidelinesPatient Index DataPsoriatic Arthritis ImpactInternational Dermatology Outcome Measures (IDEOM) initiativeRole of PSAMost study participantsPatient GlobalArthritis ImpactPsoriasis therapyOutcome measuresTrial participantsRAPID3SymptomsStudy participantsArthritisRCTsResponsive measurePSAMost participantsTrials